Compare · ETN vs MLAB
ETN vs MLAB
Side-by-side comparison of Eaton Corporation PLC (ETN) and Mesa Laboratories Inc. (MLAB): market cap, price performance, sector, and recent activity on the wire.
Summary
- ETN operates in Technology, while MLAB operates in Industrials - the two are in different parts of the market.
- ETN is the larger of the two at $155.32B, about 287.0x MLAB ($541.1M).
- Over the past year, ETN is up 5.6% and MLAB is up 38.2% - MLAB leads by 32.6 points.
- ETN has been more active in the news (7 items in the past 4 weeks vs 4 for MLAB).
- ETN has more recent analyst coverage (25 ratings vs 3 for MLAB).
- Company
- Eaton Corporation PLC
- Mesa Laboratories Inc.
- Price
- $399.86+0.90%
- $96.87+1.17%
- Market cap
- $155.32B
- $541.1M
- 1M return
- -1.95%
- -2.78%
- 1Y return
- +5.60%
- +38.19%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 7
- 4
- Recent ratings
- 25
- 3
Eaton Corporation PLC
Eaton Corporation plc operates as a power management company. Its Electrical Americas and Electrical Global segment provides electrical components, industrial components, power distribution and assemblies, residential products, single and three phase power quality products, wiring devices, circuit protection products, utility power distribution products, power reliability equipment, and services in North and South America, as well as hazardous duty electrical, emergency lighting, fire detection, explosion-proof instrumentation, and structural support systems internationally. The company's Hydraulics segment provides pumps, motors, and hydraulic power units; valves, cylinders, and electronic controls; industrial and hydraulic hoses, fittings, assemblies, thermoplastic hose and tubing products, couplings, connectors, and assembly equipment; and industrial drums and disc brakes. Its Aerospace segment offers pumps, motors, hydraulic power units, hoses and fittings, and electro-hydraulic pumps; valves, cylinders, electronic controls, electromechanical actuators, sensors, aircraft flap and slat systems, and nose wheel steering systems; thermoplastic tubing products, fittings, adapters, couplings, and sealing and ducting products; fuel pumps, sensors, valves, and adapters and regulators; and wiring connectors and cables, as well as hydraulic and bag filters, strainers and cartridges, and golf grips. The company's Vehicle segment offers transmissions, clutches, hybrid power systems, superchargers, engine valves and valve actuation systems, cylinder heads, locking and limited slip differentials, transmission controls, and fuel vapor components for the vehicle industry. Its eMobility segment provides voltage inverters, converters, fuses, onboard chargers, circuit protection units, vehicle controls, power distribution systems, fuel tank isolation valves, and commercial vehicle hybrid systems. The company was founded in 1916 and is based in Dublin, Ireland.
Mesa Laboratories Inc.
Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products in the United States, Europe, Asia, North America, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. The company's Instruments segment designs, manufactures, and markets quality control hardware and disposable products used in the healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, and environmental air sampling industries. This segment's products include dialysate meters and calibration solutions, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. The company's Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enables to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The company's Continuous Monitoring segment designs, develops, and markets systems, which are used to monitor various environmental parameters, such as temperature, humidity, and differential pressure to ensure that critical storage and processing conditions are maintained in hospitals, pharmaceutical and medical device manufacturers, blood banks, pharmacies, and laboratory environments. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.
Latest ETN
- Eaton to announce second quarter 2026 earnings on July 31, 2026
- Eaton Teams with FranklinWH to Expand Technologies for Energy Affordability and Resilience in U.S. Homes
- Eaton Names Dan T. Simpson President, Global Energy Infrastructure Solutions
- Eaton Accelerates Sustainability Impact with 40% Emissions Reduction and $2.1B in R&D Investment
- SEC Form 11-K filed by Eaton Corporation PLC
- SEC Form 11-K filed by Eaton Corporation PLC
- SEC Form 11-K filed by Eaton Corporation PLC
- SEC Form 425 filed by Eaton Corporation PLC
- SEC Form 425 filed by Eaton Corporation PLC
- SEC Form 425 filed by Eaton Corporation PLC
Latest MLAB
- MESA LABS DECLARES QUARTERLY DIVIDEND
- CAO Crennen Lyndsey Elizabeth sold $39,560 worth of shares (442 units at $89.50), exercised 726 shares at a strike of $95.10 and was granted 263 shares, increasing direct ownership by 37% to 2,020 units (SEC Form 4)
- SVP Operations Archbold Brian David exercised 3,324 shares at a strike of $95.10, was granted 1,859 shares and sold $225,187 worth of shares (2,516 units at $89.50), increasing direct ownership by 72% to 6,377 units (SEC Form 4)
- CFO Sakys John exercised 3,792 shares at a strike of $95.10, was granted 2,282 shares and sold $253,022 worth of shares (2,827 units at $89.50) as part of a pre-agreed trading plan, increasing direct ownership by 20% to 19,785 units (SEC Form 4)
- SVP Operations Archbold Brian David sold $116,558 worth of shares (1,151 units at $101.27), decreasing direct ownership by 24% to 3,710 units (SEC Form 4)
- CAO Crennen Lyndsey Elizabeth sold $11,950 worth of shares (118 units at $101.27), decreasing direct ownership by 7% to 1,473 units (SEC Form 4)
- CFO Sakys John sold $123,850 worth of shares (1,223 units at $101.27), decreasing direct ownership by 7% to 16,538 units (SEC Form 4)
- New insider Crennen Lyndsey Elizabeth claimed ownership of 1,863 shares (SEC Form 3)
- SVP Operations Archbold Brian David exercised 2,454 shares at a strike of $104.08, increasing direct ownership by 102% to 4,861 units (SEC Form 4)
- CFO Sakys John exercised 2,717 shares at a strike of $104.08, increasing direct ownership by 18% to 17,761 units (SEC Form 4)